Antibody drug conjugates
Prelude Focuses on SMARCA in AbCellera Deal and Trims Its Portfolio by Dropping Two Phase 1 Candidates
Anika Sharma
Prelude Therapeutics is undergoing a strategic shift, significantly streamlining its clinical pipeline to focus on the promising potential of its ...
AbbVie CEO reveals why it passed on Daiichi’s cancer drug
Anika Sharma
AbbVie CEO Rich Gonzalez has revealed the company’s stance on the recent ADC transaction involving Daiichi and Merck. Despite being ...
Dato-DXd Shows Efficacy in Lung Cancer, But Safety Issues Remain (ESMO 2023)
Anika Sharma
ESMO 2023: LBA12 During the Presidential Symposium at the ESMO Congress 2023 in Madrid, a study revealed that datopotamab deruxtecan, ...
Ambrx’s ARX517 Shows Promising Efficacy and Safety in Advanced Prostate Cancer (ESMO 2023)
Anika Sharma
ESMO 2023: 1804P As of the data cutoff date in September 2023, the results from the study show that increasing ...
Sotio inks $740M deal with Synaffix for ADC technology after lead drug setback
Anika Sharma
In a strategic move following the recent setback in its IL-15 asset trials, Sotio Biotech has embarked on an ambitious ...
